Nouvelle déclaration d'incident
No de la demande: 2015-5339
Numéro de référence du titulaire d'homologation: SC1667047
Nom du titulaire (nom légal complet, aucune abbréviation): Dow AgroSciences Canada Inc.
Adresse: 450-1st Street SW, Suite 2100
Ville: Calgary
État: AB
Pays: Canada
Code postal /Zip: T2P 5H1
Incident chez l'humain
Pays: CANADA
État: ALBERTA
ARLA No d'homologation 30914 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Curtail M Herbicide
Oui
Inconnu
Site: Res. - Out Home / Rés - à l'ext.maison
Non
Professionnel de la santé
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Inconnu
Non
Inconnu
Non professionnel
Application
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Aucun
Inconnu
>15 min <=2 hrs / >15 min <=2 h
>8 hrs <=24 hrs / > 8 h < = 24 h
8/15/2015 An ER doctor called about a patient with a prior history of atrial fibrillation who presented with issues related to his atrial fibrillation and was wondering if use of the product without a mask could aggravate his condition. Patient used this product about 10 hours prior to his presentation around the home. The patient used the product for about 1 hour and without a mask. There was no known exposure. No problems noted until about 9-10 hours after use when the patient presented to the ER. Patient has a history of hypotension and A-Fib that is not treated. MD did not wish to discuss case further when prompted with additional questions. It is not known if the patient received any treatments. MD did not want further follow-up.
Modérée
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. Exposure history appears to be somewhat speculative, and it is unclear as to how the exposure occurred or to what extent an exposure occurred. If direct inhalation of airborne spray occurred, respiratory irritation may occur however such symptoms are typically immediate in onset and are transient in nature. These symptoms were not reported. Based on the known toxicological profile of this pesticide, and the delayed onset of cardiac symptoms, this patients illness is not expected following incidental skin contact or possible inhalation. The reported symptoms are likely related to the individuals prior cardiac history.